BIOLOGICAL PREPARATIONS PREVENTION

Brand Owner (click to sort) Address Description
ENOCHIAN BIOSCIENCES ENOCHIAN BIOSCIENCES, INC. Century City Medical Plaza 2080 Century Park East, Suite 906 Los Angeles CA 90067 Biological preparations for the prevention and treatment of cancer and infectious diseases, namely, human immunodeficiency virus; pharmaceutical preparations for the prevention and treatment of cancer and infectious diseases; vaccine preparations; pharmaceutical preparations for use in chemotherapy; gene therapy preparations for the prevention and treatment of cancer and infectious diseases; cell therapy preparations for the prevention and treatment of cancer and infectious diseases;BIOSCIENCES;
PHAGEBANK Adaptive Phage Therapeutics, Inc. 708 Quince Orchard Road, Suite 205 Gaithersburg MD 20878 Biological preparations for the prevention and treatment of bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields; none of the aforementioned goods used in manufacturing;
PHAGEBANK THE DEPARTMENT OF THE NAVY 875 N Randolph St Arlington VA 22203 Biological preparations for the prevention and treatment of bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields; none of the aforementioned goods used in manufacturing;
SACCHARO Saccharo Inc. 6401 Chelton Drive Oakland CA 94611 Biological preparations for the prevention and treatment of diseases;Biochemicals, namely, monoclonal antibodies for scientific or research use;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. Homogeneous preparations of IL-28A, IL-28B, and IL-29 have been produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins. The cysteine mutant proteins can be shown to either bind to their cognate receptor or exhibit biological activity. One type of biological activity that is shown is an antiviral activity.